Mizuho Securities Raises Price Target on Myriad Genetics (MYGN) Following Analyst Day
Tweet Send to a Friend
Mizuho Securities reiterated a Neutral rating on Myriad Genetics (NASDAQ: MYGN), and raised the price target to $38.00 (from $32.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
